OCX
Closed
Oncocyte Corp
3.04
-0.12 (-3.80%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 3.16
Day's Range: 2.95 - 3.3086
Send
sign up or login to leave a comment!
When Written:
0.31
OncoCyte Corp is a biotechnology company that focuses on the development and commercialization of novel tests for the early detection of cancer. The company's primary focus is on the development of liquid biopsy tests that can detect cancer through a simple blood test. OncoCyte's flagship product is the DetermaVu lung cancer test, which is designed to help physicians identify lung nodules that are likely to be cancerous. The company is also developing tests for breast, bladder, and prostate cancer. OncoCyte was founded in 2009 and is headquartered in Alameda, California. The company is publicly traded on the NYSE American exchange under the ticker symbol OCX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!
When Written:
0.31
OncoCyte Corp is a biotechnology company that focuses on developing and commercializing novel tests for the early detection of cancer. The company's main product is the DetermaVu Lung Test, which uses a non-invasive liquid biopsy to detect lung cancer in high-risk individuals. The test is designed to be more accurate and less invasive than traditional diagnostic methods such as CT scans and biopsies. OncoCyte is also developing tests for breast, bladder, and prostate cancer. The company was founded in 2009 and is headquartered in Alameda, California. OncoCyte is publicly traded on the NYSE American exchange under the ticker symbol OCX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








